Skip to content

Why is it relevant?

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice

Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

Why is it relevant?
Prof. Robert F Storey, Sheffield/UK

Play Video

Share

|

Why is it relevant?

Play Video

Share

|

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice

Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

Why is it relevant?
Prof. Robert F Storey, Sheffield/UK

More Videos

Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
Jak można ograniczyć powikłania krwotoczne i koszty? | Stephan Geidel | With Polish Voice Over
Jak można ograniczyć powikłania krwotoczne i koszty? | Stephan Geidel | With Polish Voice Over
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
Why is it relevant? | Robert F Storey | Webinar 1 | 2021
Why is it relevant? | Robert F Storey | Webinar 1 | 2021
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.